{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:55:30Z","timestamp":1792616130237,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jinf.2026.106868","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:53:48Z","timestamp":1790434428000},"page":"106868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of invasive fungal infection in acute leukaemia to inform infection prevention and surveillance practice: A systematic review and meta-analyses"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-3428","authenticated-orcid":false,"given":"Priya","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma K.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-2958","authenticated-orcid":false,"given":"Chin Fen","family":"Neoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Spelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9309-9315","authenticated-orcid":false,"given":"Lisa","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s44313-025-00113-2","article-title":"Invasive fungal infections in hematologic diseases: evidence, challenges, and clinical practice","volume":"60","author":"Cho","year":"2025","journal-title":"Blood Res"},{"issue":"9","key":"10.1016\/j.jinf.2026.106868_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.21776","article-title":"Invasive fungal disease in patients treated for newly diagnosed acute leukemia","volume":"85","author":"Hammond","year":"2010","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.jinf.2026.106868_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.1105","article-title":"Invasive fungal disease associated with targeted agents for acute myeloid leukaemia: a systematic review","volume":"6","author":"Agrawal","year":"2025","journal-title":"EJHaem"},{"issue":"11","key":"10.1016\/j.jinf.2026.106868_bib4","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/j.clml.2020.06.008","article-title":"Incidence of invasive fungal infections in acute myeloid leukemia without antifungal prophylaxis","volume":"20","author":"Signorelli","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01716-2","article-title":"Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis","volume":"11","author":"Oh","year":"2021","journal-title":"Sci Rep"},{"issue":"26","key":"10.1016\/j.jinf.2026.106868_bib6","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2014-04-516211","article-title":"How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach","volume":"124","author":"Nucci","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/clinpract14010022","article-title":"Risk factors and environmental preventive actions for aspergillosis in patients with hematological malignancies","volume":"14","author":"Raposo Puglia","year":"2024","journal-title":"Clin Pract"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5694\/mja2.51446","article-title":"Acute leukaemia in Australia: outcomes have improved, but there is still much to do","volume":"216","author":"Yeoh","year":"2022","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12938-025-01403-7","article-title":"Global, regional, and national burden of acute leukemia and its risk factors from 1990 to 2021 and predictions to 2040: findings from the global burden of disease study 2021","volume":"24","author":"Han","year":"2025","journal-title":"Biomed Eng Online"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae133","article-title":"The burden of invasive fungal disease following chimeric antigen receptor T-cell therapy and strategies for prevention","volume":"11","author":"Little","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106868_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cmi.2024.01.005","article-title":"Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"30","author":"Biyun","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jinf.2026.106868_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41375-025-02586-7","article-title":"Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)","volume":"39","author":"Pagano","year":"2025","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jinf.2026.106868_bib13","article-title":"Acute lymphoblastic leukemia and invasive mold infections: a challenging field","volume":"8","author":"Stafylidis","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"9","key":"10.1016\/j.jinf.2026.106868_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18369","article-title":"Recent advances in CAR-T cell therapy for acute myeloid leukaemia","volume":"28","author":"Gao","year":"2024","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jinf.2026.106868_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104134","article-title":"Infections in haematology patients treated with CAR-T therapies: a systematic review and meta-analysis","volume":"192","author":"Reynolds","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.jinf.2026.106868_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imj.15585","article-title":"Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology\/oncology setting, 2021","volume":"51","author":"Chang","year":"2021","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/dkaa409","article-title":"Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey","volume":"76","author":"Khanina","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jinf.2026.106868_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/17474086.2024.2383401","article-title":"How can we optimize antifungal use and stewardship in the treatment of acute leukemia?","volume":"17","author":"Taynton","year":"2024","journal-title":"Expert Rev Hematol"},{"issue":"7","key":"10.1016\/j.jinf.2026.106868_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000742","article-title":"Antifungal prophylaxis in acute myeloid leukemia: new drugs, new challenges? Summary of the EHA guideline on antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel-targeted therapies","volume":"6","author":"Stemler","year":"2022","journal-title":"Hemasphere"},{"issue":"Suppl 7(Suppl 1)","key":"10.1016\/j.jinf.2026.106868_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/imj.15586","article-title":"Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021","volume":"51","author":"Khanina","year":"2021","journal-title":"Intern Med J"},{"issue":"12","key":"10.1016\/j.jinf.2026.106868_bib21","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1093\/jac\/dkaf382","article-title":"Antifungal treatment strategies and their impact on resistance development in clinical settings","volume":"80","author":"Van Rhijn","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae094","article-title":"Patterns and drivers of antifungal prescribing in acute leukemia: a retrospective cohort study","volume":"11","author":"Houston","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae046","article-title":"Informing the World Health Organization Fungal Priority Pathogens List (WHO-FPPL): a collection of systematic reviews","volume":"62","author":"Chen","year":"2024","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2026.106868_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection-position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.jinf.2026.106868_bib26","first-page":"178","article-title":"Highlights of ECIL: recommendations in invasive fungal disease in children","volume":"55","author":"Groll","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jep.12889","article-title":"Critical appraisal of nonrandomized studies-a review of recommended and commonly used tools","volume":"25","author":"Quigley","year":"2019","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00432-021-03733-0","article-title":"Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia","volume":"148","author":"Fleischmann","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"10.1016\/j.jinf.2026.106868_bib29","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00277-022-04883-y","article-title":"Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis","volume":"101","author":"Wolach","year":"2022","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.jinf.2026.106868_bib30","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/jac\/dkz303","article-title":"Clinical experience with new formulation SUBA R-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies","volume":"74","author":"Nield","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"10.1016\/j.jinf.2026.106868_bib31","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.3390\/cancers15133457","article-title":"Multicenter observational retrospective study on febrile events in patients with acute myeloid leukemia treated with Cpx-351 in \"Real-Life\": the SEIFEM experience","volume":"15","author":"Fianchi","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12879-022-07298-2","article-title":"Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2026.106868_bib33","article-title":"Outcomes of antifungal prophylaxis in high-risk haematological patients (AML under Intensive Chemotherapy): the SAPHIR prospective multicentre study","volume":"6","author":"Gangneux","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"10","key":"10.1016\/j.jinf.2026.106868_bib34","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1080\/10428194.2019.1590570","article-title":"Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program","volume":"60","author":"Paige","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.jinf.2026.106868_bib35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11046-020-00461-w","article-title":"Low rate of invasive fungal infections during induction and consolidation chemotherapy for adults with de novo acute myeloid leukemia without anti-mold prophylaxis: single-center 2002-2018 empirical\/pre-emptive approach","volume":"185","author":"Martino","year":"2020","journal-title":"Mycopathologia"},{"issue":"7","key":"10.1016\/j.jinf.2026.106868_bib36","article-title":"Bone marrow iron stores are not associated with increased risk for invasive fungal infections in patients with newly diagnosed acute leukemia or myelodysplastic syndrome in transformation: is there a relationship?","volume":"9","author":"Apostolidi","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"7","key":"10.1016\/j.jinf.2026.106868_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab113","article-title":"When azoles cannot be used: the clinical effectiveness of intermittent liposomal amphotericin prophylaxis in hematology patients","volume":"8","author":"Batchelor","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2026.106868_bib38","article-title":"Management of invasive fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation: the turin experience","volume":"11","author":"Busca","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"10.1016\/j.jinf.2026.106868_bib39","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1080\/10428194.2022.2047964","article-title":"Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax","volume":"63","author":"Chen","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib40","first-page":"18","article-title":"Real-life comparison of posaconazole versus fluconazole for primary antifungal prophylaxis during remission-induction chemotherapy for acute leukemia","volume":"8","author":"Dufresne","year":"2023","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"issue":"3","key":"10.1016\/j.jinf.2026.106868_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad134","article-title":"Breakthrough invasive fungal infection after coadministration of venetoclax and voriconazole","volume":"10","author":"Hall","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106868_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myad046","article-title":"Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: clinical features, risk factors, and posaconazole profiles","volume":"61","author":"Hong","year":"2023","journal-title":"Med Mycol"},{"issue":"S1","key":"10.1016\/j.jinf.2026.106868_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14162","article-title":"Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients","volume":"25","author":"Khatri","year":"2023","journal-title":"Transplant Infect Dis"},{"issue":"23","key":"10.1016\/j.jinf.2026.106868_bib44","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/bloodadvances.2019000930","article-title":"Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents","volume":"3","author":"Aldoss","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jmii.2018.09.006","article-title":"Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Chien","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib46","doi-asserted-by":"crossref","first-page":"S602","DOI":"10.1093\/ofid\/ofaa439.1336","article-title":"Breakthrough invasive fungal disease (IFD) in patients with acute myeloid leukemia (AML)","volume":"7","author":"Wasylyshyn","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106868_bib47","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/cid\/ciz282","article-title":"Isavuconazole prophylaxis in patients with hematologic malignancies and hematopoietic cell transplant recipients","volume":"70","author":"Fontana","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2026.106868_bib48","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.jinf.2026.106868_bib49","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/hematology.2020000098","article-title":"Updates in infection risk and management in acute leukemia","volume":"2020","author":"Logan","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.jinf.2026.106868_bib51","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/S1473-3099(17)30443-7","article-title":"Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks","volume":"17","author":"Benedict","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: a systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2026.106868_bib53","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.cmi.2025.06.003","article-title":"Fungal infections in patients with haematological malignancies in the pre-triazole era: the dawn of a new era in medical mycology","volume":"31","author":"Akova","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/tjh.2018.0007","article-title":"Invasive fungal infections in patients with hematological malignancies: emergence of resistant pathogens and new antifungal therapies","volume":"35","author":"Gamaletsou","year":"2018","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.jinf.2026.106868_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciag029","article-title":"Current epidemiology and infection characteristics of non-aspergillus mold infections: a multicenter study in Australia and New Zealand","author":"Neoh","year":"2026","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2026.106868_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14020126","article-title":"Novel strategies for preventing fungal infections-outline","volume":"14","author":"Agbadamashi","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.jinf.2026.106868_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2025.07.008","article-title":"The INTERACT study: infection prevention and surveillance practice in the care of the Australasian cancer and transplant population","author":"Garg","year":"2025","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.jinf.2026.106868_bib58","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1017\/ice.2015.280","article-title":"A survey of infection prevention and control practices among hematopoietic stem cell transplant centers","volume":"37","author":"Beam","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.jinf.2026.106868_bib59","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/jac\/dkad143","article-title":"Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"78","author":"Stemler","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2026.106868_bib60","article-title":"Outbreaks of fungal infections in hospitals: epidemiology, detection, and management","volume":"9","author":"Douglas","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhin.2010.03.014","article-title":"Point-of-use filtration method for the prevention of fungal contamination of hospital water","volume":"76","author":"Warris","year":"2010","journal-title":"J Hosp Infect"},{"issue":"6","key":"10.1016\/j.jinf.2026.106868_bib62","first-page":"636","article-title":"Fungal contaminants in drinking water regulation?","volume":"14","author":"M","year":"2017","journal-title":"A Tale Ecol Expo Purif Clin Relev"},{"issue":"2","key":"10.1016\/j.jinf.2026.106868_bib63","article-title":"What's new in prevention of invasive fungal diseases during hospital construction and renovation work: an overview","volume":"9","author":"Marekovi\u0107","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxaf005","article-title":"Efficacy of cleaning, disinfection, and sterilization modalities for addressing infectious drug-resistant fungi: a review","volume":"136","author":"Garvey","year":"2025","journal-title":"J Appl Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106868_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70043","article-title":"Key factors to consider for Candida auris screening in healthcare settings: a systematic review","volume":"68","author":"Danielsen","year":"2025","journal-title":"Mycoses"},{"issue":"24","key":"10.1016\/j.jinf.2026.106868_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244274","article-title":"At-home care program for acute myeloid leukemia induction phase in patients treated with venetoclax-based low-intensity regimens","volume":"16","author":"Mart\u00ednez-Roca","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.jinf.2026.106868_bib67","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/imj.15593","article-title":"Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology\/oncology setting, 2021","volume":"51","author":"Fernando","year":"2021","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.jinf.2026.106868_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2011.03477.x","article-title":"Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)","volume":"17","author":"Ruiz-Camps","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jinf.2026.106868_bib69","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.chom.2022.04.013","article-title":"Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria","volume":"30","author":"Drummond","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.jinf.2026.106868_bib70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chest.2024.08.046","article-title":"Diagnosis and prevention of invasive fungal infections in the immunocompromised host","volume":"167","author":"Wahab","year":"2025","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jinf.2026.106868_bib71","first-page":"528","article-title":"Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis","volume":"55","author":"Eigl","year":"2017","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106868_bib72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/arm91030016","article-title":"Invasive pulmonary aspergillosis in coronavirus disease 2019 patients lights and shadows in the current landscape","volume":"91","author":"Tsotsolis","year":"2023","journal-title":"Adv Respir Med"},{"issue":"2","key":"10.1016\/j.jinf.2026.106868_bib73","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106868_bib74","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.pathol.2023.03.011","article-title":"Panfungal PCR on formalin-fixed, paraffin-embedded tissue: to proceed or not proceed?","volume":"55","author":"Sparks","year":"2023","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.jinf.2026.106868_bib75","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/S1473-3099(23)00377-8","article-title":"Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients","volume":"24","author":"Teh","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2026.106868_bib76","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cmi.2023.05.011","article-title":"Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: a systematic scoping review and narrative synthesis","volume":"29","author":"Reynolds","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jinf.2026.106868_bib77","article-title":"Antifungal policy and practice across five countries: a qualitative review","volume":"11","author":"Denning","year":"2025","journal-title":"J Fungi (Basel)"},{"issue":"9","key":"10.1016\/j.jinf.2026.106868_bib78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2026.106868_bib79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-023-00861-x","article-title":"The WHO fungal priority pathogens list as a game-changer","volume":"21","author":"Fisher","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2026.106868_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1547450","article-title":"Artificial intelligence in hospital infection prevention: an integrative review","volume":"13","author":"El Arab","year":"2025","journal-title":"Front Public Health"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:26:48Z","timestamp":1792614408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445326001945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0163445326001945"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106868","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of invasive fungal infection in acute leukaemia to inform infection prevention and surveillance practice: A systematic review and meta-analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106868"}}